These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 33889938)

  • 1. Spatial and Temporal Variability in Antineoplastic Drug Surface Contamination in Cancer Care Centers in Alberta and Minnesota.
    Jeronimo M; Arnold S; Astrakianakis G; Lyden G; Stewart Q; Petersen A; Chambers C; Malard Johnson D; Zimdars E; Kaup H; Davies HW
    Ann Work Expo Health; 2021 Aug; 65(7):760-774. PubMed ID: 33889938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring Surface Contamination by Antineoplastic Drugs in Italian Hospitals: Performance-Based Hygienic Guidance Values (HGVs) Project.
    Sottani C; Grignani E; Oddone E; Dezza B; Negri S; Villani S; Cottica D
    Ann Work Expo Health; 2017 Oct; 61(8):994-1002. PubMed ID: 29028251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The application of novel field measurement and field evaluation protocols for assessing health care workers' exposure risk to antineoplastic drugs.
    Astrakianakis G; Jeronimo M; Griffiths A; Colombo M; Kramer D; Demers PA; Hon CY
    J Occup Environ Hyg; 2020 Sep; 17(9):373-382. PubMed ID: 32615872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing wipe sampling strategy guidance for assessing environmental contamination of antineoplastic drugs.
    Arnold S; Jeronimo M; Astrakianakis G; Kunz M; Petersen A; Chambers C; Malard Johnson D; Zimdars E; Davies HW
    J Oncol Pharm Pract; 2023 Dec; 29(8):1816-1824. PubMed ID: 35924415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antineoplastic drug contamination on the hands of employees working throughout the hospital medication system.
    Hon CY; Teschke K; Demers PA; Venners S
    Ann Occup Hyg; 2014 Jul; 58(6):761-70. PubMed ID: 24644303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing variability of antineoplastic drugs handling practices in clinical settings.
    Arnold S; Kaup HM
    J Occup Environ Hyg; 2019 Dec; 16(12):757-762. PubMed ID: 31621520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occupational Exposure Assessment to Antineoplastic Drugs in Nine Italian Hospital Centers over a 5-Year Survey Program.
    Sottani C; Grignani E; Cornacchia M; Negri S; Cuna FSRD; Cottica D; Bruzzese D; Severi P; Strocchi D; Verna G; Leso V; Iavicoli I
    Int J Environ Res Public Health; 2022 Jul; 19(14):. PubMed ID: 35886450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hygienic guidance values for wipe sampling of antineoplastic drugs in Swedish hospitals.
    Hedmer M; Wohlfart G
    J Environ Monit; 2012 Jul; 14(7):1968-75. PubMed ID: 22692549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface wipe sampling for antineoplastic (chemotherapy) and other hazardous drug residue in healthcare settings: Methodology and recommendations.
    Connor TH; Zock MD; Snow AH
    J Occup Environ Hyg; 2016 Sep; 13(9):658-67. PubMed ID: 27019141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface contamination with nine antineoplastic drugs in 109 canadian centers; 10 years of a monitoring program.
    Chabut C; Tanguay C; Gagné S; Caron N; Bussières JF
    J Oncol Pharm Pract; 2022 Mar; 28(2):343-352. PubMed ID: 33567975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A quantitative LC-MS method to determine surface contamination of antineoplastic drugs by wipe sampling.
    Kåredal M; Jönsson R; Wetterling M; Björk B; Hedmer M
    J Occup Environ Hyg; 2022 Jan; 19(1):50-66. PubMed ID: 34723774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter evaluation of a new closed system drug-transfer device in reducing surface contamination by antineoplastic hazardous drugs.
    Bartel SB; Tyler TG; Power LA
    Am J Health Syst Pharm; 2018 Feb; 75(4):199-211. PubMed ID: 29339374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface contamination with ten antineoplastic drugs in 83 Canadian centers.
    Chauchat L; Tanguay C; Caron NJ; Gagné S; Labrèche F; Bussières JF
    J Oncol Pharm Pract; 2019 Jul; 25(5):1089-1098. PubMed ID: 29726786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot study: External surface contamination of gemcitabine and 5-fluorouracil on drug packaging.
    Kåredal M; Özdemir J; Tinnert A; Wetterling M; Hedmer M
    J Oncol Pharm Pract; 2024 Jan; 30(1):9-14. PubMed ID: 36916178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter study of environmental contamination with cyclophosphamide, ifosfamide, and methotrexate in 66 Canadian hospitals: A 2016 follow-up study.
    Roland C; Caron N; Bussières JF
    J Occup Environ Hyg; 2017 Aug; 14(8):661-669. PubMed ID: 28574754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-sectional evaluation of surface contamination with 9 antineoplastic drugs in 93 Canadian healthcare centers: 2019 results.
    Palamini M; Gagné S; Caron N; Bussières JF
    J Oncol Pharm Pract; 2020 Dec; 26(8):1921-1930. PubMed ID: 32114883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application and assessment of a regular environmental monitoring of the antineoplastic drug contamination level in pharmacies - the MEWIP project.
    Kiffmeyer TK; Tuerk J; Hahn M; Stuetzer H; Hadtstein C; Heinemann A; Eickmann U
    Ann Occup Hyg; 2013 May; 57(4):444-55. PubMed ID: 23125441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pilot assessment of the antineoplastic drug contamination levels in British Columbian hospitals pre- and post-cleaning.
    Chu WC; Hon CY; Danyluk Q; Chua PP; Astrakianakis G
    J Oncol Pharm Pract; 2012 Mar; 18(1):46-51. PubMed ID: 21737485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of an Environmental Monitoring to Assess the Practices and Control the Risk of Occupational Exposure to Cyclophosphamide in Two Sites of a French Comprehensive Cancer Center.
    Acramel A; Fouque J; Blondeel-Gomes S; Huguet S; Rezai K; Madar O; Escalup L
    Ann Work Expo Health; 2022 Nov; 66(9):1215-1223. PubMed ID: 35596678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External contamination of antineoplastic drug containers from a Canadian wholesaler.
    Hilliquin D; Bussières JF
    J Oncol Pharm Pract; 2020 Mar; 26(2):423-427. PubMed ID: 31446868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.